[go: up one dir, main page]

EP1732943A4 - Nouvelles sequences nucelotidiques et d'acides amines, et leurs dosage et procedes d'utilisation pour le diagnostic du cancer du sein - Google Patents

Nouvelles sequences nucelotidiques et d'acides amines, et leurs dosage et procedes d'utilisation pour le diagnostic du cancer du sein

Info

Publication number
EP1732943A4
EP1732943A4 EP05718182A EP05718182A EP1732943A4 EP 1732943 A4 EP1732943 A4 EP 1732943A4 EP 05718182 A EP05718182 A EP 05718182A EP 05718182 A EP05718182 A EP 05718182A EP 1732943 A4 EP1732943 A4 EP 1732943A4
Authority
EP
European Patent Office
Prior art keywords
assays
diagnosis
methods
amino acid
acid sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05718182A
Other languages
German (de)
English (en)
Other versions
EP1732943A2 (fr
Inventor
Amir Toporik
Dvir Dahary
Rotem Sorek
Sarah Pollock
Zurit Levine
Pinchas Akiva
Alexander Diber
Amit Novik
Osnat Sella-Tavor
Michal Ayalon-Sofer
Shira Walach
Shirley Sameah-Greenwald
Ronen Shemesh
Naomi Keren
Maxim Shklar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Compugen USA Inc
Original Assignee
Compugen USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compugen USA Inc filed Critical Compugen USA Inc
Priority claimed from PCT/IB2005/000433 external-priority patent/WO2005072050A2/fr
Publication of EP1732943A2 publication Critical patent/EP1732943A2/fr
Publication of EP1732943A4 publication Critical patent/EP1732943A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
EP05718182A 2004-01-27 2005-01-27 Nouvelles sequences nucelotidiques et d'acides amines, et leurs dosage et procedes d'utilisation pour le diagnostic du cancer du sein Withdrawn EP1732943A4 (fr)

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
US53912904P 2004-01-27 2004-01-27
US53912804P 2004-01-27 2004-01-27
US62065604P 2004-10-22 2004-10-22
US62092404P 2004-10-22 2004-10-22
US62091804P 2004-10-22 2004-10-22
US62087404P 2004-10-22 2004-10-22
US62085304P 2004-10-22 2004-10-22
US62100404P 2004-10-22 2004-10-22
US62097504P 2004-10-22 2004-10-22
US62097404P 2004-10-22 2004-10-22
US62091704P 2004-10-22 2004-10-22
US62091604P 2004-10-22 2004-10-22
US62113104P 2004-10-25 2004-10-25
US62814504P 2004-11-17 2004-11-17
US62825104P 2004-11-17 2004-11-17
US62823104P 2004-11-17 2004-11-17
US62815604P 2004-11-17 2004-11-17
US62816704P 2004-11-17 2004-11-17
US62817804P 2004-11-17 2004-11-17
US62810104P 2004-11-17 2004-11-17
US62811104P 2004-11-17 2004-11-17
US62012304P 2004-11-17 2004-11-17
US62813404P 2004-11-17 2004-11-17
US62811204P 2004-11-17 2004-11-17
PCT/IB2005/000433 WO2005072050A2 (fr) 2004-01-27 2005-01-27 Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du sein

Publications (2)

Publication Number Publication Date
EP1732943A2 EP1732943A2 (fr) 2006-12-20
EP1732943A4 true EP1732943A4 (fr) 2011-01-12

Family

ID=37398553

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05718182A Withdrawn EP1732943A4 (fr) 2004-01-27 2005-01-27 Nouvelles sequences nucelotidiques et d'acides amines, et leurs dosage et procedes d'utilisation pour le diagnostic du cancer du sein

Country Status (1)

Country Link
EP (1) EP1732943A4 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100723A1 (en) * 2000-07-26 2003-05-29 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030124128A1 (en) * 2001-06-21 2003-07-03 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100723A1 (en) * 2000-07-26 2003-05-29 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030124128A1 (en) * 2001-06-21 2003-07-03 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] XP002611793, retrieved from ebi accession no. EM_NEW:GX181231 Database accession no. GX181231 *
DATABASE EMBL [online] XP002611794, retrieved from ebi accession no. EM_PAT:GX181230 Database accession no. GX181230 *
DATABASE Geneseq [online] 29 January 2004 (2004-01-29), XP002611795, retrieved from EBI accession no. GSP:ADE05342 Database accession no. ADE05342 *
FLETCHER G C ET AL: "hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan", BRITISH JOURNAL OF CANCER 20030224 GB LNKD- DOI:10.1038/SJ.BJC.6600740, vol. 88, no. 4, 24 February 2003 (2003-02-24), pages 579 - 585, XP002611796, ISSN: 0007-0920 *

Also Published As

Publication number Publication date
EP1732943A2 (fr) 2006-12-20

Similar Documents

Publication Publication Date Title
EP1973945A4 (fr) Nouvelles séquences de nucléotides et d'acides aminés et leurs procédés d'utilisation pour le diagnostic
WO2006131928A3 (fr) Nouvelles sequences de nucleotides et d'acides amines, leurs dosages et methodes d'utilisation en vue du diagnostic
WO2004066941A3 (fr) Profils d'expression destines au cancer du colon et procedes d'utilisation
WO2007039903A3 (fr) Nouveaux nucleotides et nouvelles sequences d'acides amines, et bioessais et procedes d'utilisation associes a des fins de diagnostic
IL185501A0 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2007109236A8 (fr) Empreintes digitales micro-arn pendant une mégacaryocytopoïese
MY153198A (en) Inhibitors of protein aggregation
WO2005059108A3 (fr) Profils d'expression geniques et procedes d'utilisation
WO2005044990A3 (fr) Sequences d'acide nucleique differemment exprimees utilisees comme biomarqueurs du cancer
WO2007058968A3 (fr) Profils d’expression genique et procedes d’utilisation
WO2004078035A3 (fr) Profiles d'expression pour le cancer du sein et methodes d'utilisation
WO2005032495A3 (fr) Profils d'expression genique et leurs methodes d'utilisation
SI1766056T1 (sl) Oligonukleotidi za diagnozo raka na prsih
WO2007120955A3 (fr) Gènes agissant sur les performances de la mémoire humaine
EP1742654A4 (fr) Anticorps anti-lfl2 pour le diagnostic, le pronostic et le traitement d'un cancer
EP1954826A4 (fr) Nouvelles sequences de nucleotides et d'acides amines, ainsi que tests et procedes d'utilisation de ces sequences a des fins de diagnostic
GB0400976D0 (en) Methods of diagnosis
WO2006054297A3 (fr) Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et leurs procedes d'utilisation pour le diagnostic
WO2005072050A9 (fr) Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du sein
EP1774046A4 (fr) Nouvelles sequences d'aminoacides et de nucleotides, et dosages et methodes d'utilisation afferentes dans le diagnostic du cancer du poumon
WO2005072053A9 (fr) Nouveaux nucleotides et sequences d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic du cancer du colon
EP1732943A4 (fr) Nouvelles sequences nucelotidiques et d'acides amines, et leurs dosage et procedes d'utilisation pour le diagnostic du cancer du sein
IL174465A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
AU2005288710A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
ZA200703482B (en) B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060825

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SHKLAR, MAXIM

Inventor name: KEREN, NAOMI

Inventor name: SHEMESH, RONEN

Inventor name: SAMEAH-GREENWALD, SHIRLEY

Inventor name: WALACH, SHIRA

Inventor name: AYALON-SOFER, MICHAL

Inventor name: SELLA-TAVOR, OSNAT

Inventor name: NOVIK, AMIT

Inventor name: DIBER, ALEXANDER

Inventor name: AKIVA, PINCHAS

Inventor name: LEVINE, ZURIT

Inventor name: POLLOCK, SARAH

Inventor name: SOREK, ROTEM

Inventor name: DAHARY, DVIR

Inventor name: TOPORIK, AMIR

DAX Request for extension of the european patent (deleted)
RIN1 Information on inventor provided before grant (corrected)

Inventor name: SHKLAR, MAXIM

Inventor name: KEREN, NAOMI

Inventor name: SHEMESH, RONEN

Inventor name: SAMEAH-GREENWALD, SHIRLEY

Inventor name: WALACH, SHIRA

Inventor name: AYALON-SOFER, MICHAL

Inventor name: SELLA-TAVOR, OSNAT

Inventor name: NOVIK, AMIT

Inventor name: DIBER, ALEXANDER

Inventor name: AKIVA, PINCHAS

Inventor name: LEVINE, ZURIT

Inventor name: POLLOCK, SARAH

Inventor name: SOREK, ROTEM

Inventor name: DAHARY, DVIR

Inventor name: TOPORIK, AMIR

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

RIC1 Information provided on ipc code assigned before grant

Ipc: C07H 21/02 20060101ALI20100526BHEP

Ipc: C12Q 1/68 20060101ALI20100526BHEP

Ipc: G01N 33/53 20060101AFI20100526BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101ALI20101201BHEP

Ipc: C07K 14/47 20060101ALI20101201BHEP

Ipc: G01N 33/574 20060101ALI20101201BHEP

Ipc: G06F 19/00 20110101ALI20101201BHEP

Ipc: G01N 33/48 20060101AFI20101201BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20101210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110308